Increased CD-3, CD-4, and CD-68 staining occurred in the tumor transplant area around the regions of tumor necrosis in immune-reconstituted TPV/eGFP subjects when compared to immunocompromised TPV/eGFP-treated mice. This evidence concerns the gene CD4 and neoplasm.